Cross-fund · 5 holders
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
CUSIP 61559X104
5
Tracked holders
$97.6M
Aggregate value
5,314,339
Shares
5
Active funds
Funds holding MLTX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Citadel | Multi-Strategy | Q1 2026 | $38.8M | 0.01% | -213,562 | -9.3% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $25.5M | 0.03% | +596,018 | +77.2% |
| BlackRock | Institutional | Q1 2026 | $19.0M | — | +735,258 | +256.6% |
| Millennium | Multi-Strategy | Q1 2026 | $10.7M | — | -226,630 | -28.2% |
| Vanguard | Institutional | Q4 2025 | $3.5M | — | +145,907 | +121.3% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.